graph Evidence gap map comparisons
nivolumab based treatment
nivolumab alone
Extensive stage SCLC (Es-SCLC) - maintenance (M) 2   
Comparator:  vs placebo; 
Risk of bias:  low;   some concerns;   high;  NA;